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Stlmmal'y 
The phorbol ester phorbol myristate acetate (PMA) induces a rapid downregulation of CD4 
from the surface of T cells and lymphocytic  cell lines, as well as from CD4-transfected nonlymphoid 
cells. Here we have studied the mechanisms of this phorbol ester-induced CD4 modulation. 
Using HeLa-CD4 or NIH-3T3-CD4 cells, in which the endocytosis of CD4 is not influenced 
by  the  protein  tyrosine kinase p56  ~k,  we  show  that  PMA  enhanced the  uptake  of CD4, 
increasing the rate of CD4 endocytosis three to five-fold, and doubling the proportion of CD4 
found inside the cells. Trafficking of a CD4 mutant lacking the major portion of the cytoplasmic 
domain, as well as fluid phase endocytosis were not affected by PMA treatment. Studies in which 
clathrin-coated pits were disrupted through the use of hypertonic media indicated that both the 
constitutive and PMA-induced CD4 uptake occurred through coated vesicles. Electron microscopy 
demonstrated directly that PMA increases the association of CD4 with coated pits. Immunofluo- 
rescent staining of internalized CD4 showed that PMA also diverted CD4 from the early endosome- 
plasma membrane recycling pathway to a mannose 6-phosphate receptor-containing late endosomal 
compartment. In lymphoid or p56t~Lexpressing transfected cells, these effects were preceded by 
the PMA-induced dissociation of CD4 and p56  uk, which released  CD4 and made possible 
increased endocytosis and altered intraceUular trafficking. Together these results indicate that phorbol 
esters have multiple effects on the normal endocytosis and trafficking of CD4, and suggest that 
phosphorylation may influence the interaction of CD4 with coated pits. 
C 
D4 is a type I integral cell surface glycoprotein that is 
expressed primarily on thymocytes and MHC class II-re- 
stricted peripheral T cells (1, 2). The molecule is a member 
of the Ig supergene family and appears to function in T lym- 
phocyte ontogeny (3) and in the activation of mature CD4 + 
T  cells (4). In addition, CD4 acts as the primary receptor 
for the HIVs (5). The ectodomain of CD4 contains sites that 
can interact with nonpolymorphic  regions of the MHC class 
II antigens and also bind to the gp120 component of the HIV 
envelope glycoproteins (6,  7). In addition, the cytoplasmic 
domain of CD4 interacts with a lymphocyte-specific m-related 
protein tyrosine kinase, p56  ~k (8), and CD4 may therefore 
also function in signal transduction. 
Although the primary site of CD4 function appears to be 
at the cell surface, it is known that various physiological and 
experimental stimuli can induce its downregulation. Indeed, 
loss of cell surface CD4 could be involved in the generation 
of CD4-CD8 +  thymocytes, and  the  downregulation of 
CD4 on peripheral T cells may contribute to the induction 
of anergy and tolerance.  Exposure of specific T  cells to an 
appropriate antigen (9-11),  or to cross-linking Abs against 
CD4 (12, 13), the CD3-TCK complex (11), or CD2 (14) can 
induce a reduction in cell surface CD4 expression.  In addi- 
tion, cell surface CD4 levels can be modulated during HIV 
infection (15), after treatment with a soluble form of HIV 
gp120 (16, 17) or after exposure to gangliosides (18, 19). The 
modulation of CD4 that occurs during antigen encounter 
can be mimicked by treating cells with phorbol esters (9, 10). 
These activators of protein kinase C have been shown to cause 
transient phosphorylation of the CD4 cytoplasmic domain 
(9, 20, 21), which may then induce CD4 downmodulation 
by endocytosis (21-23).  However, the mechanisms by which 
CD4 is cleared from the cell surface have not been elucidated 
in detail,  and, although it appears that internalized CD4 is 
degraded after phorbol ester stimulation (23-26), the exact 
fate of the downregulated CD4 molecules has not been de- 
termined. 
We have previously demonstrated that on transfected non- 
lymphoid (HeLa-CD4 or NIH-3T3-CD4) and monocytic cell 
lines (HL-60 and U937), CD4 is constitutively internalized 
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through coated pits and coated vesicles and, at steady state, 
•40%  of the CD4 is found inside the cells. In contrast, the 
CD4 expressed in lymphoid cell lines is not internalized (28), 
but is restricted to the cell surface through its interaction 
with p56  ~k (30). In the present study, we have examined the 
mechanisms of phorbol ester-induced CD4 modulation. Since 
p56  ~  dearly has a  significant influence on the endocytic 
trafficking of CD4 (30), we have used CD4-transfected non- 
lymphoid cells for these experiments. We demonstrate that 
human CD4 expressed on HeLa-CD4 or NIH-3T3-CD4 cells 
can be downregulated by phorbol ester, and that this modu- 
lation is not dependent on the presence  of p56  ~. The ini- 
tial effect of phorbol ester is to increase the rate of CD4 en- 
docytosis through coated pits. Furthermore, the level of CD4 
recycling observed in the presence of  phorbol esters is reduced 
as CD4 is diverted from the recycling pathway between early 
endosomes and the plasma membrane to a mannose 6-phos- 
phate receptor-containing late endosomal compartment in 
the  endocytic pathway.  In  lymphoid or  p56~-expressing 
transfected cells, phorbol ester-induced CD4 downregula- 
tion appears to occur by a similar mechanism. However, the 
enhanced CD4 endocytosis is only possible after the rapid 
dissociation of CD4 from p56 ~k. 
Materials and Methods 
Materials.  Horseradish  peroxidase (HILP)  ~ type II and PMA 
were purchased  from Sigma  Chemical  Co. Ltd. (Poole,  Dorset, UK). 
A stock solution of PMA (2 mg/ml in ethanol) was stored at 
- 20~  The anti-CD4 mAb I.eu3a  was obtained  from Becton  Dick- 
inson & Co. (Mountain View, CA), and Fab' fragments were pre- 
pared as described (27). The Q4120 Ab, developed  by Dr. Quentin 
Sattentau (Centre d'Immunologie de Marseille-Luminy,  INSERM- 
CNRS, MarseiUe, France) (31) was provided by the Medical Re- 
search Council AIDS Directed Programme Reagents Programme 
(South Mimms, Potters Bar, Hefts, UK). Abs or Fab' fragments 
were radioiodinated as described (27, 28). Q4120 was labded with 
tetramethyl-rhodamine isothiocyanate (TPdTC;  Cambridge Bio- 
Science, Cambridge, UK) according to the manufacturer's instruc- 
tions, whereas the fluorescein-conjugated  mAb to the transferrin 
receptor (TfR), L01,1, was purchased from Becton Dickinson & 
Co. A rabbit polyclonal serum specific  for the cation independent 
mannose 6-phosphate receptor (CI-MPR) was kindly provided by 
Dr. W. J. Brown (Coruell University, Ithaca, NY) and has been 
previously characterized (32). The rabbit antiserum to p56  k~, anti- 
p56  ~k (KERP), raised against a peptide covering residues 478-509 
of murine p56  I'i, has been described (30). A second antiserum, 
anti-p56  ~k (RNGS), was raised against a peptide covering residues 
39-64 of routine p56  kk starting with the sequence N'-RNGS (pre- 
pared by Dr. Torben Saermark, University of  Copenhagen, Copen- 
hagen, Denmark, for the European Community Concerted Ac- 
tion programme),  and was  aflfinity  purified using  the peptide 
1 Abbreviations used in this paper: BM, binding medium; CD4qt% CD4 
molecules  from  which  the cytoplasmic  domain  has been deleted;  CI-MPR, 
cation independent mannose 6-phosphate receptor; HRP, horseradish 
perc~idase; MES, morpholinoethanesulfonic  acid; TfR, transferrin  receptor; 
TRITC, tetramethylrhodamine  isothiocyanate. 
immobilized on Reactigel (Pierce and Warriner, Chester, UK). 
Peroxidase-conjugated, and  rhodamine-  or  fluorescein-labeled 
anti-rabbit  and anti-mouse reagents were purchased from Pierce 
and Warriner. 
Cells and Cell Culture.  Adherent HeLa and NIH-3T3 cell lines 
transfected with the cDNAs of human CD4 or mutant CD4~v  '-, 
as well as M22, an NIH-3T3-CD4 cell line which has been super- 
transfected  with the routine kk eDNA, were cultured as described 
(28, 30) and used 3 d after subculture unless otherwise indicated. 
CD4~y  '- is a CD4 mutant from which the major portion of the 
cytoplasmic domain (comprising amino acids 403--433) has been 
deleted (33). The lymphocytic cell line SupT1 was grown in ILPMI 
1640 medium supplemented with 10% FCS, 100 U/ml of peni- 
cillin, and 0.1 mg/ml streptomycin and was used when growing 
exponentially. 
Ab Binding and Endocytosis Assays.  To determine levels of CD4 
remaining on the cell surface after phorbol ester treatment, cells 
were cooled by washing twice in ice-cold binding medium (BM; 
RPMI 1640 lacking bicarbonate, supplemented with 0.2% BSA, 
and 10 mM Hepes, pH 7.4) and incubated for 2 h on ice in medium 
containing 0.3 nM lzSI-labeled anti-CD4 mAb (Leu3a or Q4120) 
or 0.5 nM lzSI-Fab' of Leu3a. Unbound Ab or Fab' was washed 
away in three changes of medium and two rinses of PBS, before 
cells were harvested  by dissolving in 0.2 M NaOH for V-counting. 
Internalization of CD4 was measured as described (27). Briefly, 
adherent cells grown in 16-mm tissue culture wells were labeled 
with radioiodinated anti-CD4 Abs or Fab' fragments, as detailed 
above, and warmed to 37~  to allow endocytosis  of the Ab tracer. 
At various times cells were cooled and either harvested directly, 
or cell surface l~I-label was removed by washing in cold BM 
buffered to pH 2 or 3 with 10 mM morpholinoethanesulfonic acid 
(MES) and HC1 for Ab or Fab' fragments, respectively. For the 
suspension cell line SupT1, the assay  was adapted as described (28). 
The proportion of acid resistant to total cell counts was calculated 
for each time point and plotted. For recycling studies, cells were 
labeled as above, incubated in BM at 37~  for 30 min, cooled, 
surface stripped in cold medium at pH 3 and returned to BM at 
37~  for various times before analysis  as described above. To study 
Ab degradation, all warm media from the endocytosis and recy- 
cling studies were collected, and aliquots analyzed by 3~-counting 
before and after precipitation with 20% TCA for 1 h on ice. 
To inhibit endocytosis  through coated  pits, cells  were  preincubated 
for 5 min at 0-4~  in hypertonic  medium (0.45 M sucrose  in ILPMI 
1640 medium lacking bicarbonate, supplemented with 0.2% BSA, 
20 mM MES, and 20 mM succinic acid, pH 5.7) and the endocy- 
tosis assay  was performed in the presence of hypertonic medium. 
Fluid phase endocytosis of HP,  P was assayed  as described (30). 
Electron Micwscopic  Localization of CD4.  The distribution of CD4 
at the cell surface and during endocytosis was determined as de- 
scribed (28, 30). Briefly,  HeLa-CD4 cells grown on 22-ram  ~  glass 
coverslips were labeled  with 8 nM Lcu3a and 9 nm protein A gold 
(provided by Dr. Gareth Grif~ths, EMBL, Heidelberg, Germany; 
28) and warmed to 37~  for 1-4 rain in the presence or absence 
of 100 ng/ml PMA. Cells were cooled, fixed, and embedded as 
described (28, 30) and ultrathin sections were examined with an 
electron microscope (model CM12; Philips Analytical, Cambridge, 
UK). For quantitative analysis,  cells were examined  systematically, 
noting the location of every gold particle encountered. 
Imraunofluorescence Endocytosis Assay.  To follow CD4 endocy- 
tosis, HeLa-CD4 ceils were grown on glass coverslips, and labeled 
at 0--4~  with 8 nM Leu3a or rhodamine-conjugated Q4120 for 
2 h. The cells were washed extensively  and then warmed to 37~ 
for various times to allow endocytosis  of the Ab-labehd CD4 mol- 
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on ice and washed in medium adjusted to pH 2 to remove cell sur- 
face mAb. Subsequently, all ceils were fixed in 3% paraformalde- 
hyde in PBS for 30 rain on ice and quenched with 50 mM NH4C1. 
Some samples were permeabilized with 0.1% Triton X-100 to re- 
veal internalized Ab. To detect the Leu3a Ab, cells were stained 
with rhodamine-labeled goat anti-mouse diluted 1:2,000. Calls on 
some coverslips were counter stained  in rabbit anti-CI-MPR at 
1:200 followed by FITC-conjugated goat anti-rabbit diluted 1:1,000, 
whereas the TfR was detected using FITC-conjugated L01.1 diluted 
1:100. Cells were washed and mounted in Moviol, and observed 
by confocal microscopy (model MRC 600; Bio-Rad Laboratories, 
Heine1 Hempstead, Hefts, UK). 
Imraunoprecipitation and Iraraunoblotting.  M22 cells were washed 
once in Ca2+/Mg2+-free  PBS and harvested by scraping into PBS. 
The cells were centrifuged at 1,500 rpm for 5 rain at 4~  and 
resuspended in 20 mM Tris-HC1 lysis buffer, pH 8.0, containing 
3% NP-40, 150 mM NaCI, 2 mM EDTA, and protease inhibitors 
(1 mM PMSF and 10/~g/ml each of chymostatin, leupeptin, an- 
tipain, and pepstatin) for 10 rain on ice. Detergent-insoluble mate- 
rial was removed by centrifugation at 4~  for 30 min at full speed 
in a benchtop microfuge. The supernatants were collected and ali- 
quots taken for protein determination using the bicinchoninic acid 
assay (34),  immunoprecipitation, and immunoblotting. 
To precipitate CD4 and CD4/p56 kt complexes, aliquots of each 
lysate containing equal amounts of cell protein were precleared by 
incubation for 30 min at 4~  with 50 #1 packed, prewashed pro- 
tein A-Sepharose (Sigma  Chemical Co.). Q4120 covalently cou- 
pled to protein A-Sepharose (20 #1 of a 50% slurry) was then added 
and the lysate incubated for 2 h at 4~  The beads were collected 
by centrifugation (1 min at 1,000 rpm) and washed three times 
with lysis buffer and twice with 25 mM Hepes, pH 7.2, containing 
0.1% NP-40, resuspended in 20 p.1SDS-PAGE sample buffer without 
reducing agents, and run on 10% SDS-PAGE minigels. Aliquots 
of the lysate before immunoprecipitation were mixed 4:1 with a 
5 x  concentrated sample  buffer, and run on identical minigels. 
After electrophoresis, cellular proteins were transferred to nitrocel- 
lulose.  The blots were blocked using  10% dried skimmed milk 
powder (Marvel) in PBS at 4~  overnight, and then incubated in 
primary Ab.  The affinity-purified anti-p56  ~k (RNGS) and anti- 
p56  tk (KERP) were used at dilutions of 1:1,000 and 1:500, respec- 
tively,  whereas Q4120 was used at  1.6 ~tg/ml.  After incubation 
with Ab and washing, the blots were probed with peroxidase-con- 
jugated goat anti-rabbit or goat anti-mouse Abs and developed 
using an enhanced chemiluminescence detection system (Amersham 
International, Amersham, Bucks, UK) according to the manufac- 
turer's instructions. 
Results 
Downregulation of CD4 on Transfected NonlTmphocytic Cells. 
Phorbol esters such as PMA have been shown to cause rapid 
downmodulation of CD4 from the surface of human PBL 
and thymocytes, as wall as a number of  lymphocytic or myeloid 
call lines (9, 14, 22, 35). In addition, PMA can downregulate 
CD4 expressed on nonlymphoid HeLa cells after transfec- 
tion (24, 33, 36). Using a binding assay  with a radioiodinated 
anti-CD4 mAb, we determined the concentration dependence 
of CD4 downregulation by PMA on 3-d-old HeLa-CD4 cells. 
Half-maximal downregulation (EDs0) was observed with 0.5 
ng/ml PMA (0.8 riM). Thus, the potency of PMA on HeLa- 
CD4 cells is similar to that reported for PBL (22, 37,  38). 
As already described for lymphocytic  cells (9, 14, 22), PMA 
(100 ng/ml) induced rapid CD4 downregulation on HeLa- 
CD4 cells, with the majority of the CD4 molecules being 
removed from the cell surface in 1 h (36). Cell surface CD4 
expression remained at a low level (20-30% of that on un- 
treated cells) for up to 8-10 h, but subsequently the amount 
of cell surface CD4 increased again, recovering to near the 
original levels after 24-48 h of continuous treatment with 
phorbol ester. This recovery of CD4 expression was not due 
to inactivation  of the phorbol ester, since PMA-containing 
medium taken from cells after 24 h was still able to induce 
CD4 downregulation in fresh HeLa-CD4 cells. Studies with 
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Figure  1.  Effect  of PMA on CD4 endocytosis  in HeLa-CD4 cells. (A) 
Time course of internalization of CD4 on 3-d-old HeLa-CD4 cells in the 
presence (0) or absence (O) of 100 ng/ml PMA. CD4 endocytosis  was 
traced with nSI-labeled  Fab' fragments of Leu3a. The plot shows the ratios 
of acid-resistant t2SI-Fab' to the total cell-associated label after various 
times at 37~  The initial portion of the graph (0--8 min) is expanded (B). 
1211  Pelchen-Matthews et al. Table  1.  Effect of PMA on CD4 Endocytosis 
Cell line  Tracer  used  Endocytosis rate 
Control 
Percent  internal 
at 60 min 
Plus PMA 
Percent  internal  No. of 
Endocytosis rate  at 60 min  experiments 
HeLa-CD4 
(3-d-old) 
HeLa-CD4 
(2-d-old) 
NIH-3T3-CD4 
% /min 
12sI-Fab'  2.0  28 
12SI-Leu3a  1.8  _+ 0.9  37  _+  1 
12SI-Q4120  2.6  _+ 0.2  46  _+ 7 
t2SI-Leu3a  3.9  +_  1.2  41  _+  101 
% /min 
11.3  78  1" 
8.4  _+ 3.3  62  +  14  7 
6.4  +_ 0.2  79  +  11  2 
12.9  +_ 2.8  88  2 
* Data from multiple experiments are expressed as mean _+ SD. 
Internal at 30-60 min. 
cydoheximide indicated that the recovery requires protein syn- 
thesis (data not shown), and may involve the PMA-induced 
downregulation of protein kinase C (39, 40), as well as effects 
of the phorbol ester on CD4 transcription  and translation 
(41). This has not been examined further in the present study. 
Downregulation was dependent on the presence of the CD4 
cytoplasmic domain, and was not observed in HeLa cells trans- 
fected with a mutant CD4 lacking the cytoplasmic domain 
(HeLa-CD4'Yt-;  33,  36,  42). 
Like the HeLa-CD4 cells, NIH-3T3 cells transfected with 
CD4 (NIH-3T3-CD4) downregulated their cell surface CD4 
in response to phorbol ester.  The  amount  of CD4 down- 
regulation on NIH-3T3-CD4 cells was consistently greater 
than that observed on HeLa-CD4 cells, with >70%  of the 
CD4 being removed from the cell surface during  the first 
30 rain  of PMA treatment. 
Thus,  CD4 can be downregulated from the cell surface 
of lymphoid and nonlymphoid cells by similar concentrations 
of phorbol esters.  This indicates that CD4 downregulation 
is not T  cell dependent  and does not require the presence 
of p56  ~k.  As CD4 downregulation  is believed to occur by 
endocytosis, and CD4 endocytosis is influenced by p56  ~k ex- 
pression, we first sought to understand  the mechanisms of 
downregulation  in the p56~k-negative  nonlymphoid  cells. 
Effects of  Phorbol Esters on CD4 Endocytosis.  The CD4 mol- 
ecules expressed in HeLa-CD4 and NIH-3T3-CD4 cells are 
constitutively internalized and recycled (27, 29). To study the 
effects of phorbol ester on this constitutive CD4 endocytosis, 
ceils were surface labeled at  0-4~  with  12SI-labded anti- 
CD4 mAb or Fab' fragments. After 2 h, the cells were washed 
and warmed to 37~  in the presence or absence of 100 ng/ml 
PMA. At various times, the level of internalized  12sI tracer 
was detected by acid washing as described in Materials and 
Methods.  The result of a typical CD4 endocytosis experi- 
ment is shown in Fig.  1. PMA increased the rate of CD4 
endocytosis on 3-d-old HeLa-CD4 cells by four to sixfold. 
This increase was observed after a brief lag of about 2 min 
(Fig. 1 B). Comparable results were obtained when CD4 en- 
docytosis was measured using Fab' fragments or intact anti- 
CD4 mAb (Table 1).  Similar  effects were seen on 2-d-old 
HeLa-CD4 or on NIH-3T3-CD4 cells, although the increase 
in CD4 endocytosis was less striking, possibly because these 
cells had somewhat higher CD4 endocytosis rates in the ab- 
sence of phorbol ester.  In addition  to its effect on the rate 
of CD4 endocytosis, PMA increased the steady state distri- 
bution of CD4 in the cells from 40 to about 80%  (Table 
1). This effect was generally more pronounced on 2-d-old 
HeLa-CD4 and on the NIH-3T3-CD4  cells. 
To investigate whether the internalized  Ab ligands were 
degraded, the media in which the cells had been warmed for 
endocytosis were precipitated with TCA. The level of TCA- 
soluble 12si (representing degraded Ab ligand), when calcu- 
lated as a proportion  of the amount  of 12SI-ligand initially 
bound to the cells, was proportional to the amount of inter- 
nalized mAb, regardless of the presence of PMA. When levels 
of TCA-soluble t2sI were calculated as a proportion of the 
endocytosed plus degraded counts (i.e.,  as a proportion  of 
all the activity that was or had been inside the cells), significant 
increases in TCA-soluble counts (30-40%) were only apparent 
in cells treated with PMA for 2 h or longer.  At these long 
time points,  significant dissociation of the mAb from CD4 
could have occurred, especially since CD4 and mAb would 
have entered acidic  organdies.  The appearance of degraded 
activity may not,  therefore,  reflect the fate of CD4. 
These data indicated that the one important effect of phorbol 
ester is to increase the rate ofCD4 endocytosis in HeLa-CD4 
or NIH-3T3-CD4 cells. This shifts the steady state distribu- 
tion of CD4 so that  more than  80% is intracellular,  with 
a concomitant  decrease in cell surface CD4. 
The Specificity of the Phorbol Ester Effect on CD4 Endocy- 
tosis.  Previous  experiments  have  indicated  that  phorbol 
ester-induced downregulation of CD4 is dependent on the 
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Figure 2.  Time course of internalization of 12SI-labeled  Leu3a in HeLa- 
CD4~y  '- cells that express CD4 molecules from which the cytoplasmic 
domain has been deleted. The plot shows the ratios of acid-resistant lzsI- 
Leu3a to the total cell-associated label on cells warmed in the presence 
(0) or absence (O) of 100 ng/ml of PMA. 
presence of the cytoplasmic domain (33,  36, 42).  We have 
shown that CD4cy  '-  molecules can be internalized by bulk 
flow transport through coated pits in both HeLa and lym- 
phoid cell lines  (28).  To determine whether phorbol ester 
treatment also affected the internalization of CD4cy  '-,  we 
measured endocytosis on HeLa-CD4cY  '- cells. Virtually iden- 
tical CD4 endocytosis curves were obtained in the presence 
or absence of PMA (Fig. 2). This observation suggests that 
the PMA-induced enhancement of CD4 endocytosis described 
above was specific for full-length CD4 molecules, and not 
due to a general stimulation of bulk flow endocytosis by 
phorbol ester, as has been described for example, for macro- 
phages (43, 44). To demonstrate directly that phorbol esters 
do not stimulate the basal endocytic capacity in HeLa-CD4 
cells, we measured the rates of fluid phase endocytosis using 
HRP. PMA did not affect the initial rate of fluid uptake mea- 
sured over the first  10 rain in HRP medium (fluid uptake 
occurred at 6  x  10 -4 nl/min/#g of cell protein). However, 
cells incubated with PMA for longer periods (>1 h) accu- 
mulated 20-25%  more fluid than control cells, suggesting 
that PMA-treated cells may retain more of the internalized 
marker than untreated cells. 
Together these results indicate that in these HeLa-CD4 cells, 
phorbol esters do not have a significant  effect on the vesic- 
ular traffic from the cell surface, and hence that the phorbol 
ester-induced increase in CD4 uptake is not due to a general 
stimulation of endocytosis. 
Phorbol  Esters Increase  CD4 Endoq/tosis Through Coated Pits. 
In HeLa and NIH-3T3 cells, CD4 is internalized through 
clathrin-coated pits and vesicles (28, 30), suggesting that it 
contains sequences in its cytoplasmic domain that allow it 
to cluster into coated pits. To examine whether the increased 
uptake of CD4 observed in the presence of phorbol ester also 
occurs by this pathway, we used hypertonic media (45) to 
inhibit the formation of clathrin-coated vesicles (46). In our 
hands, incubation in media containing 0.45 M sucrose gave 
a more complete, yet reversible, inhibition of CD4 internali- 
zation than methods of acidifying the cytosol (cf. 47, 48), 
although long-term cell viability was improved when the 
hypertonic medium was slightly acidified (Pdchen-Matthews, 
A., and M. Marsh, manuscript in preparation). Treatment 
of HeLa-CD4 cells for 1 h with PMA in the presence  of 
medium containing 0.45 M sucrose and adjusted to pH 5.7 
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Figure 3.  The effect of hypertonic medium on CD4 downregulation 
and endocytosis on 3-d-old HeLa-CD4 cells. (.4) Cell surface expression 
of CD4 on HeLa-CD4 cells pretreated for 1 h in binding medium (I), 
medium containing 100 ng/ml PMA (2), or in hypertonic medium con- 
taining 100 ng/ml PMA (3). After incubation, cells were cooled and levels 
of CD4 remaining on the cell surface determined using 0.3 nM l~I-labeled 
Q4120. The plot shows binding of tzSI-Q4120 compared to the untreated 
cells (B/Bo) after correction for cellular protein content. (B) Time courses 
of internalization  of CD4 in the presence (filled symbols) or absence (open 
symbols) of 100 ng/ml PMA in normal (circles, solid lines) or hypertonic 
medium (triangles, dashed lines). CD4 endocytosis was traced with 0.3 nM 
12Sl-Q4120. The plot shows the ratios of acid-resistant 12SI-Q4120  to the 
total cell-associated label after various times at 37~ 
1213  Pelchen-Matthews et al. Table  2.  Effect of PMA  on the Distribution of Gold-labeled CD4 on HeLa-CD4  Cells 
Particles over  Particles over 
Total No. of  noncoated  coated pits 
Time at 37~  particles counted  plasma membrane  and vesicles 
Internalized 
particles  Unclassified 
%  %  % 
A: Control 
0  511  475  (93.0)  21"  (4.1) 
1 min  349  310  (88.8)  18  (5.2) 
2 min  346  314  (90.8)  18  (5.2) 
3 min  416  330  (79.3)  23  (5.5) 
4 min  316  252  (79.7)  8  (2.5) 
B: Plus PMA 
1 min  378  325  (86.0)  27  (7.1) 
2 rain  329  253  (76.9)  34  (10.3) 
3 min  372  275  (73.9)  33  (8.9) 
4 min  289  185  (64.0)  15  (5.2) 
0 
18 
10 
56 
48 
25 
29 
52 
82 
(o.o) 
(5.2) 
(2.9) 
(13.5) 
(15.2) 
(6.6) 
(8.8) 
(14.o) 
(28.4) 
15 
3 
4 
7 
8 
1 
13 
12 
7 
Distribution of Leu3a/protein A-gold particles were analyzed as detailed in the text and in reference 28. 
* Only particles observed immediately juxtaposed to the clathrin coat were counted in this category. 
almost completely inhibited CD4 downregulation (Fig. 3 A). 
When CD4 internalization  was assayed directly, the hyper- 
tonic medium inhibited CD4 endocytosis by more than 90%. 
The increased CD4 endocytosis observed in the presence of 
PMA was also inhibited to a similar extent (Fig.  3 B), sug- 
gesting that both constitutive and PMA-induced uptake of 
CD4 occurred through  coated pits and vesicles. 
The findings that PMA does not stimulate vesicular traffic 
from the surface of HeLa-CD4 cells and that  inhibition  of 
coated vesicle--mediated endocytosis inhibits phorbol ester-in- 
duced downregulation  suggested that  the increased rate of 
CD4 endocytosis may be due to increased association of CD4 
with clathrin-coated pits. This was demonstrated directly by 
immunolabeling electron microscopy.  2-d-old HeLa-CD4 cells 
were labeled on ice with Leu3a and protein A-gold.  After 
washing to remove any free gold conjugate, cells were warmed 
to 37~  in the presence or absence of PMA, fixed, and pre- 
pared for electron microscopy. Control experiments in which 
the kinetics of 12sI-Leu3a uptake were examined after incu- 
bation with protein A-gold showed that internalization  of 
the mAb was not affected by the gold probe (28). In the ab- 
sence of phorbol ester, 4.0-5.5% of the gold particles at the 
cell surface were found in close apposition to coated plasma 
membrane (Table 2), in agreement with our previous study 
(28). In samples treated with PMA, gold particles were also 
observed in coated pits and vesicles (Fig. 4). When the dis- 
tribution of labeled CD4 was determined at increasing times 
after warming in PMA medium,  there was a transient  in- 
crease in the number of gold particles seen in coated pits or 
vesicles,  peaking with more than  10% of all gold particles 
(or 12% of the gold at the cell surface) adjacent to coated 
plasma membrane.  This represents a threefold increase over 
the basal coated pit association of CD4, and can account for 
the increase in the rate of CD4 endocytosis observed (cf. Table 
1). Significantly,  the increased association of CD4 with coated 
pits is observed just before the enhanced endocytosis of CD4 
as measured biochemicaUy (the lag shown in Fig. 1 B). Since 
ligand located in coated pits at the cell surface is still acces- 
sible to acid washing  in the biochemical experiments,  and 
the lifetime of a coated pit at the cell surface is believed to 
be about 1-2 min (49-51), the increased association of CD4 
with coated pits can completely explain the phorbol ester-in- 
duced enhancement  of CD4 uptake. 
Effects  of Phorbol Esters on CD4 Recycling.  To investigate 
whether PMA also affects the recycling of internalized CD4, 
3-d old HeLa-CD4 cells were loaded with 12SI-labeled anti- 
CD4 Fab' fragments by warming in the presence or absence 
of 100 ng/ml PMA. The cells were then briefly treated with 
acid medium at 4~  to remove any Fab' remaining  on the 
cell surface, and reincubated at 37~  Subsequently, the cells 
were subjected to a second acid wash and recycling detected 
as a decrease in the level of acid-resistant  12SI-Fab' tracer as- 
sociated with the cells, and a loss of the previously internal- 
ized tracer intact (i.e., TCA precipitable) into the medium. 
In the absence of PMA, the recycling of CD4 observed was 
similar to our previous results (27).  In contrast,  very little 
recycling was observed in cells that had been loaded in the 
presence of PMA (Fig. 5). Identical results were observed when 
CD4 recycling was monitored using intact 12SI-labeled Ab. 
Furthermore,  there was very little recycling of internalized 
tracer when cells were loaded with the 12SI-mAb in the ab- 
sence of phorbol ester, and PMA only added to the recycling 
medium (data not shown). As in the endocytosis experiments, 
the level of anti-CD4 tracer found inside the cells at steady 
state was increased from about 40% in the absence of phorbol 
ester to about 80%  with PMA. 
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Figure 5.  Effect  of PMA on recycling  of CD4. 3-d-old cultures of HeLa- 
CD4 cells were surface labeled with lzSI-labeled  Fab' fragments of Leu3a, 
and then warmed for 30 min to 37~  in the presence (0) or absence (O) 
of 100 ng/ml PMA to allow the tracer to be internalized. Cells were then 
cooled and all szsI-Fab'  removed from the cell surface by acid washing. 
The time course of lzSI-Fab'  recycling was then determined by rewarming 
the cells to 37~  for the times indicated. Cells were returned to ice and 
the acid-resistant activity determined after a second acid wash. The plot 
shows the ratios of acid-resistant 12SI-Fab'  to the total cell-associated label. 
1.00 
0.75 
Figure 4.  Electron microscopic localization of CD4 in PMA-treated 
HeLa-CD4 cells. 2-d-old HeLa-CD4 cells were labeled on ice with 8 nM  0.50 
Leu3a followed by protein A-gold, washed, and warmed to 37~  in the 
presence of 100 ng/ml PMA for 2 min (A and B) or 3 min (C).  Scale  ~  0.25 
bar,  100 nm. 
Modeling  ofCD4 Endocytosis.  The studies described above 
have demonstrated that one of the main effects of phorbol 
ester is to increase CD4 endocytosis through coated pits. To 
determine if this  increase in  CD4  internalization is  alone 
sufficient to explain CD4  downregulation,  we designed a 
simple mathematical model of CD4  endocytosis.  The ex- 
perimentally determined CD4 internalization and recycling 
rates were used to calculate surface and internal CD4 levels 
and the proportion of  internalized molecules at different times 
using an iterative routine. Thus, for 3-d-old HeLa-CD4 cells, 
the model was set with 60%  of the CD4 molecules at the 
cell surface,  40% in the endosome compartment, internali- 
zation at  a rate of 2%  per min, and recycling back to the 
cell surface at 3% of the internal level per rain (27, 28), thereby 
maintaining a steady state. To model our endocytosis experi- 
ments, only the pool of molecules initially at the cell surface 
was considered labeled. This yielded a CD4 uptake curve that 
corresponded closely to the actual data (open circles in Fig. 
6 A). Similarly, when only molecules initially internal were 
considered labeled, the resulting curve (Fig.  6 B) resembled 
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Figure 6.  Mathematical modeling of CD4 endocytosis (A) and recy- 
cling (B) during endocytosis at 2% per min (O) or 14% per min (0). 
For details, see text. 
the CD4 recycling plot determined experimentally (Fig.  5). 
To imitate the effect of the phorbol ester, the endocytosis rate 
in the model was increased to 10-14% per min, whereas all 
other parameters were maintained. This altered the steady 
state distribution of CD4 so that the proportion of CD4 at 
1215  Pelchen-Matthews et al. Figure 7.  The distribution  of internalized CD4 in the presence of PMA. 2-d-old HeLa-CD4 cells were labeled with Leu3a at 4~  and then incubated 
at 37~  for 1 h in the absence (,4 and D) or presence (B, C, E, and F) of 100 ng/ml PMA. Cells were then fixed and stained with anti-mouse rhodamine 
second Ab to reveal CD4 at the cell surface (A-C). Alternatively, cell surface mAb was removed by acid washing before the cells were fixed, permeabi- 
lized, and stained with anti-mouse rhodamine to reveal internalized Ab (D-F). (C and F) Phase contrast views of B and E, respectively. All images 
are of 2-#m thick optical sections. Scale bars,  10 #m. 
the cell surface decreased from 60 to about 20%, effectively 
giving downregulation. Endocytosis (Fig. 6 A) and recycling 
plots (Fig. 6 B) calculated under these conditions again cor- 
responded closely to the experimental data. 
Thus, an increase in CD4 endocytosis and consequent shift 
in the steady state distribution of the cellular CD4 could ex- 
plain the CD4 endocytosis and recycling curves observed bio- 
chemically. However, in the endocytosis experiments we did 
observe some degradation of internalized 12SI-mAb tracer by 
TCA precipitation (see above).  Furthermore, a number of 
reports have suggested that, upon phorbol ester stimulation, 
internalized CD4 is rapidly degraded in lysosomes (23-26). 
We previously showed by immunofluorescent staining that 
in NIH-3T3-CD4 cells CD4 is internalized into vesicles dis- 
tributed throughout the cytoplasm and resembling early en- 
dosomes (52).  If phorbol ester treatment simply alters the 
steady state between CD4 internalization and recycling, then 
a similar distribution of internalized CD4 should be observed 
in the presence of PMA, although the quantity of CD4 in 
the intracellular compartment would be increased.  To test 
this, we followed the fate of internalized CD4 by immuno- 
fluorescent staining. 
Phorbol Esters Alter the Distribution of  Internalized CD4.  As 
in the biochemical endocytosis experiments, 2-d-old HeLa- 
CD4 cells were labeled with anti-CD4 mAb at 4~  and then 
incubated at 37~  in the presence or absence of PMA, before 
processing to reveal cell surface or internalized mAb (Fig. 
7). In unstimulated cells, this revealed CD4 at the cell sur- 
face (Fig.  7 A), and in intraceUular vesicular  structures lo- 
cated throughout the cytoplasm (Fig.  7 D). Early after the 
addition of phorbol ester (5 and 10 rain), the internalized 
CD4-anti-CD4 complexes were observed in a similar distri- 
bution. At later times (30 min-1 h), cell surface CD4 had 
become largely undetectable (Fig. 7 B), whereas the internal- 
ized anti-CD4 mAb was located in dusters of vesicles in the 
juxta-nudear region of the cells (Fig.  7 E). To identify the 
intracellular compartments further, we performed double- 
staining studies, using the TfR and the CI-MPR as markers 
for early and late endosomes, respectively (53). In unstimu- 
lated cells which had internalized a TRITC-labeled anti-CD4 
mAb for 1 h, counter-staining with a FITC-conjugated anti- 
TfK mAb, revealed that most of the CD4-containing vesicles 
were also stained for the TfK (Fig. 8, A and B), and are there- 
fore likely to be early endosomes. In contrast, CD4 internal- 
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Figure  8.  Colocalizafion  of  internalized CD4 with the Tfl~.  or CI-MPlL. 
2-d-old HeLa-CD4 cells were labeled with TKITC-Q4120  (.4 and B) or 
Leu3a (C-F) at 4~  and then incubated at 37~  for I h in the presence 
(C and D) or absence (.4, B, E, and F) of 100 ng/ml PMA, and internal- 
ized anti-CD4 was detected as described in Fig. 7. In the absence  of PMA, 
CD4-containing vesicles (-4) could be costained with FITC-labeled anti- 
TfK mAb (B), whereas in the presence of PMA,  CD4 (C) colocalized 
with the CI-MPK (D). In the absence of PMA, CD4 (E) remained in 
vesicles similar to those observed in A and B, which did not costain with 
the CI-MPR (F). The figure shows optical sections of thickness ~3/zm 
(.4 and B) or 1 /zm (C-F). Scale bars, 10/~m. 
ized for I  h in the presence of PMA accumulated in thejuxta- 
nuclear region in structures that could be costained with Abs 
to the CI-MPR (Fig. 8, C  and D). No significant colocaliza- 
tion with the CI-MPR was observed in ceils that had inter- 
nalized CD4 in the absence of PMA (Fig.  8, E  and F).  To- 
gether  these data indicate  that CD4  internalized  into early 
endosomes is, in the presence of PMA, diverted from the re- 
cycling pathway to a CI-MPR-containing late endosome com- 
partment.  Thus,  in  addition  to its  effect on  CD4  endocy- 
tosis,  PMA also altered the trafficking of internalized  CD4 
inside  the  cells. 
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Figure  9.  Effect  of PMA on CD4 endocytosis  in p56~k-expressing  cells. 
Time courses of internalization of CD4 on SupT1 (A), p56  ~  transfected 
M22 cells (B), and the p56kl-negative parental NIH-3T3-CD4 cells (C) 
in the presence (Q) or absence (O) of 100 ng/ml PMA. CD4 endocytosis 
was traced with 12SI-labeled  anti-CD4 mAb Q4120. The plots show the 
ratios of acid-resistant 12SI-mAb  to the total cell-associated  labd after var- 
ious times at 37~ 
The Role of p56  ~  in Phorbol Ester-Induced CD4 Downregu- 
lation.  As demonstrated  above, in p56~-negative  cells ex- 
pressing CD4  after transfection,  PMA increases the rate of 
CD4 internalization and reroutes the internalized CD4 mol- 
ecules to later compartments of the endocytic pathway. Since 
p56  ~k has been shown to regulate CD4 endocytosis (30), and 
since the CD4  expressed on T  cells,  thymocytes,  and lyre- 
1217  Pdchen-Matthews et al. Figure 10.  PMA treatment  causes  dissociation  of CD4 and p56  ~k in 
M22 cells. M22 cells were incubated  in medium  containing 100 ng/ml 
PMA at 37~  At various times, cells were  cooled, washed, and lysed. 
Cell lysates  were  directly  analyzed  by SDS-PAGE, or CD4 was immuno- 
precipitated  from  the lysates  before  SDS-PAGE  and blotting  for CD4 (top) 
or p56/~ (bottom). 
phoid cell lines can also be downregulated (9, 22), we inves- 
tigated the effect of PMA on CD4 endocytosis in p56 ~k- 
expressing cells. In the lymphoid cell line SupT1, very little 
uptake of CD4 was observed in the absence of phorbol ester 
(0.2% per min; 28), and PMA stimulated CD4 endocytosis 
more than 20-fold, to 4.2% per min (Fig. 9 A). The p56 ~L 
transfected NIH-3T3-CD4 cell line M22 (30) responded simi- 
larly to PMA: CD4 endocytosis was increased 16-fold, from 
0.24% per rain to 3.8% per rain (Fig. 9 B). Significantly, 
in M22 cells a lag could be observed before the increased CD4 
endocytosis, and PMA-stimulated  CD4 endocytosis was not 
as rapid, nor as extensive as that observed on NIH-3T3-CD4 
cells lacking p56  ~  (Fig. 9 C). 
The association of CD4 and p56  ~k was studied by anal- 
yzing lysates of  PMA-treated M22 cells by Western blotting 
before or after immunoprecipitation of CD4. This demon- 
strated that PMA induced a very rapid dissociation of CD4 
and p56  ~k (Fig. 10). Quantitative densitometry of the blots 
indicated that more than 50% of p56  ~k had dissociated from 
CD4 within 2 min of  the addition of  PMA, and CD4 precipi- 
tates from lysates of cells that had been treated with PMA 
for 5 min contained less than 10% of the amount p56  kk as- 
sociated with CD4 in untreated cells. The rapid dissociation 
of CD4 and p56  ~k therefore preceded the increase in CD4 
endocytosis (Fig.  9 B),  and the time taken  for p56  ~  and 
CD4 to dissociate may explain the lag in the increase of  CD4 
endocytosis observed in  these cells. The level of CD4  or 
p56  ~k detectable in the lysates did not vary significantly over 
the time course examined. Hence, in p56Uk-expressing  cells, 
the increase in CD4 endocytosis is preceded by the dissocia- 
tion of CD4 from p56  uk, thereby allowing CD4 to interact 
with coated pits. 
Discussion 
The observation that CD4 is downmodulated  when T cells 
are stimulated by APCs or through cross-linking with Abs 
suggests that the control of plasma membrane CD4 levels 
is important in T  cell physiology  and function. Antigen- 
induced CD4 downregulation  can be mimicked  by treatment 
of cells with phorbol esters, allowing biochemical and mor- 
phological analysis of the mechanisms involved. Downregu- 
lotion occurs by endocytosis (21-23) and appears to require 
phosphorylation of  serine residues in the cytoplasmic domain 
of the molecule, in particular of Set408 (33, 36). In T cells, 
phorbol ester treatment leads to the dissociation of p56  kk 
and CD4  (54),  and recent data indicates  that  p56  kk dis- 
sociates before CD4 downregulation (55, 56). Internalized 
CD4 is believed  to be directed to lysosomes  and there degraded 
(23-26).  Here we have examined the cellular mechanisms of 
CD4 dowrtregulation induced by phorbol ester. Our studies 
indicate that dowrtregulation is a multistep process, involving 
both increased  CD4 endocytosis  and altered  endosomal sorting. 
In addition, the downregulation in p56k~-containing  cells in- 
volves an initial  dissociation of the CD4-p56 ~  complex. 
Phorbol Ester-induced Endocytosis of CD4.  Under normal 
conditions, the CD4 expressed in HeLa-CD4 and NIH-3T3- 
CD4 cells is constitutively internalized through coated pits 
and vesicles. Here we demonstrated that within minutes of 
the addition of phorbol ester, there was a three- to fivefold 
increase in the rate of CD4 internalization.  Control experi- 
ments indicated that PMA does not modulate fluid phase en- 
docytosis in HeLa-CD4 cells and does not affect the uptake 
and cycling properties  of CD4cr  t- molecules. Thus, the in- 
creased uptake of CD4 induced by phorbol ester is not due 
to general effects on vesicular traffic from the cell surface, 
but must be due to an increased association of CD4 with 
endocytic coated pits.  This was confirmed in studies with 
hypertonic media,  which inhibit coated vesicle formation, 
and by electron microscope observation of the association of 
CD4 with coated pits  and vesicles. 
Recently,  several motifs have been identified that allow 
plasma membrane receptors to interact with components of 
clathrin-coated pits and lead to rapid endocytosis of  these mol- 
ecules. Most of  these motifs consist of  four to six amino acids 
with flanking aromatic or large hydrophobic residues (e.g., 
sequences of  the form ar-x-x-ar or ar-x-x-x-x-ar),  where one 
of  the aromatic residues  is frequently a tyrosine (57, 58). Where 
information is available, these structures show a strong ten- 
dency to form/3 turns,  and the substitution of amino acids 
which would disrupt the/3 turn has been shown to reduce 
the efficacy  of  these endocytosis signals. The cytoplasmic do- 
main of CD4 does not contain such a motif. Nonetheless, 
the fact that we observe endocytosis of CD4 and clustering 
into coated pits indicates that an alternative signal(s) must 
exist (59). Recently, Letourneur and Klausner (60) suggested 
that a pair of  leucine residues forms part of the signal respon- 
sible for the endocytosis and lysosomal targeting of the y 
and ~ subunits  of CD3.  A di-leucine sequence is found in 
CD4 (Leu413 and Leu414), and Shin et al. (24) have reported 
that these leucine residues, as well as other hydrophobic amino 
acids (Met407 and Ile410) are required for CD4 downregula- 
tion. Hence the di-leucine in CD4 may be a component of 
the endocytosis signal. 
Previously it has been demonstrated that phorbol esters 
induce a rapid transient  phosphorylation of serine residues 
in the cytoplasmic domain of CD4 (9, 21, 36), and that mu- 
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regulation (33, 36, 42). The serine at position 408 is believed 
to be the most important of the three cytoplasmic serine 
residues in this respect (36).  Although the effects of these 
residues on phorbol ester-induced downregnlation have been 
recorded, their role in CD4 endocytosis has not been evalu- 
ated, and it is undear why phosphorylation of Ser408 should 
increase the efficiency  of CD4 endocytosis. In contrast to many 
serine phosphorylation sites that are located at the tip of 3 
turn structures (61), the residues surrounding Set408 show 
a strong tendency to form an o~ helix (24). Phosphorylation 
of CD4 might be expected to influence the structure of this 
helix and thereby alter the disposition of sequences involved 
in  endocytosis.  The  role  of  phosphorylation  in  coated 
vesicle-mediated endocytosis has been controversial (58). How- 
ever, our studies indicate that PMA directly increases the as- 
sociation of CD4 with coated pits and hence the rate of CD4 
endocytosis, and that this may be one situation in which phos- 
phorylation does create or enhance an endocytosis signal. 
Phorbol Ester-induced Endosomal Sorting of CD4.  Modeling 
of CD4 endocytosis suggests that the PMA-induced increase 
in the rate of CD4 endocytosis and the consequent alteration 
of the steady state distribution of CD4 between the cell sur- 
face and the endosome compartment could account for the 
observed downregulation of CD4. However, several previous 
studies suggested that CD4 internalized in the presence of 
PMA may be diverted from the endosome compartment and 
degraded in lysosomes. We used immunofluorescence  micros- 
copy to demonstrate directly that PMA affects the distribu- 
tion of the CD4-anti-CD4 mAb complexes internalized from 
the cell surface. Thus, in unstimulated cells, internalized mAb 
was located in vesicular organelles throughout the cytoplasm 
which costained with Abs to the TfR and correspond to early 
endosomes. After PMA treatment, the distribution of CD4 
was altered,  so that the bulk of the internalized anti-CD4 
mAb was seen clustered in a perinuclear region of the cell. 
In contrast to the early endosomes, these perinuclear dusters 
could be costained with Abs to the CI-MPR and may repre- 
sent components of the late endosome compartment. Thus 
CD4 internalized into early endosomes in the presence of 
phorbol  ester  is  diverted from the  constitutive recycling 
pathway to the late endosome/lysosome pathway, and as a 
consequence, there is a reduction in the recycling of internal- 
ized CD4. 
These observations imply that, in addition to the effects 
on endocytosis, the phorbol ester-induced phosphorylation 
of CD4 may also generate a signal that targets internalized 
CD4 to late endosomes and lysosomes. As with the endocy- 
tosis signal,  the precise nature of this sorting signal is un- 
clear. However, as truncation experiments (24) suggest that 
downregulation requires the membrane proximal half of the 
cytoplasmic domain of CD4, this signal may also involve, 
or overlap with, the L-L sequence. Significantly,  it has re- 
cently been reported that phosphorylation of the cytoplasmic 
domain of the CI-MPK and of the polymeric Ig receptor 
may be involved in the endosomal sorting or targeting of 
these molecules (62, 63). For the CI-MPK one of the phos- 
phorylation sites is close to an L-L sequence that has been 
implicated in sorting to late endosomes (62,  64). 
CD4 Downregulation in Lymphoid Cells.  Phorbol ester-in- 
duced CD4 downregnlation in nonlymphoid cells occurs 
through a combination of increased  CD4 endocytosis and 
sorting of the internalized CD4 molecules to CI-MPR-con- 
taining late endosomes and lysosomes.  In lymphoid cdls, 
p56  ~  prevents  CD4 entry into coated pits. To understand 
whether phorbol ester induces a relocation of p56  ~k together 
with CD4, or whether other mechanisms might account for 
CD4 downregnlation in these cells, we analyzed the interac- 
tion of p56  ~  and CD4 in the NIH-3T3-CD4/p56  ~ cell line 
M22 (30).  These cells also downregulate CD4 in response 
to phorbol ester, although the rate of CD4 internalization 
is slower than that seen in phorbol ester-treated HeLa-CD4 
and NIH-3T3-CD4 cells and is similar to that observed on 
lymphoid cells. Significantly, compared with NIH-3T3-CD4 
ceils, there is a lag after the addition of phorbol ester to M22 
cells before significant endocytosis of CD4 is observed. When 
we immunoprecipitated  CD4 from phorbol ester-treated M22 
cells, we found that p56  ~  was dissociated from CD4 with 
a tl/2 of 1-2 rain.  Thus, the dissociation appears to occur 
during the lag described above and to precede the onset of 
CD4 internalization. The region of the CD4 cytoplasmic do- 
main that interacts with p56  ~i is known to involve two cys- 
teine residues at positions 420 and 422, a region that is not 
required for downregulation (65, 66). Nevertheless, it is con- 
ceivable that conformational changes in the cytoplasmic do- 
main of CD4 induced by serine phosphorylation may dis- 
rupt the interaction with p5C  k. 
The dissociation of CD4 from p56  ~k alone would release 
CD4 and result in CD4 uptake with similar kinetics and to 
a similar extent as the constitutive CD4 endocytosis observed 
in nonlymphoid cells (i.e., 2-3% per min, and 40% internal 
at steady state).  This vcould lead to a partial reduction of 
ceU surface CD4 levels. However, CD4 downregulation in- 
duced by PMA in peripheral T  ceils and lymphocytic cells 
is much more rapid and extensive (21, 22). Thus, dissocia- 
tion of CD4 and p56  ~k cannot alone account for the level 
of downregnlation observed (55, 56) and downregnlation is 
likely also to involve the changes in endocytosis and trafficking 
of CD4 described for the HeLa-CD4 cells. Indeed, the rates 
of CD4 endocytosis observed in PMA-treated lymphocytic 
cell lines are increased more than 20-fold (e.g., to 4.2% per 
min in SupT1 cells, see above) and exceed the rates of consti- 
tutive CD4 endocytosis in nonlymphocytic cdls (cf. Table 
1). The effect of PMA on CD4 endocytosis is likely to be 
greater than this, as asynchronous and/or incomplete dissoci- 
ation of p56  ~k and CD4 will cause an underestimate in the 
observed rate of PMA-stimulated CD4 endocytosis in p56  ~- 
expressing cells. Thus PMA must also significantly increase 
CD4 internalization in lymphocytic cells. 
In conclusion, we have demonstrated that phorbol ester-in- 
duced CD4 downregnlation involves a series of sequential 
changes in the trafficking properties of CD4. First, in p56  ~k- 
containing CD4 + cells, phorbol ester stimulates dissociation 
of CD4 and pSC  ~. The released CD4 is then able to interact 
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increase the clustering of CD4 into coated pits and thereby 
increase the rate of CD4 endocytosis. Finally, phorbol esters 
induce the redistribution of internalized CD4 from the con- 
stitutive recycling pathway to degradative pathways, leading 
to delivery of CD4 to CI-MPR-containing late endosomes 
and lysosomes. Although these events have been observed in 
this study after stimulation with phorbol ester, it is likely 
that other stimuli, such as ligation of the TCR by antigen, 
would lead to CD4 downregulation by similar mechanisms. 
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